First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care
Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing…
Imugene Limited (ASX:IMU)
About Imugene Limited
Key Information
IMU In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 10/01/2025 | Application for quotation of securities - IMU | 23.72KB | 2.1K |
| 10/01/2025 | Price Sensitive PS Imugene Receives $11.7m R&D Tax Refund | 138KB | 13K |
| 03/01/2025 | Price Sensitive PS First Australian Patient Dosed in Phase 1b azer-cel Trial | 166.55KB | 91K |
| 24/12/2024 | Proposed issue of securities - IMU | 20.62KB | 17K |
| 23/12/2024 | Notice of Extraordinary General Meeting/Proxy Form | 463.88KB | 1.0K |
| 23/12/2024 | Price Sensitive PS Issuance of Convertible Notes & Warrants for up to $46m | 282.37KB | 67K |
| 20/12/2024 | Azer-cel Accepted for Presentation at ASTCT Tandem Meetings | 145.54KB | 31K |
| 19/12/2024 | Price Sensitive PS Imugene Confirms Pending Receipt of c.$11m R&D Tax Refund | 143.5KB | 53K |